GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 74 filers reported holding GALENA BIOPHARMA INC in Q1 2016. The put-call ratio across all filers is 0.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $8,000 | -20.0% | 23,219 | 0.0% | 0.00% | – |
| Q2 2016 | $10,000 | -68.8% | 23,219 | 0.0% | 0.00% | – |
| Q1 2016 | $32,000 | -5.9% | 23,219 | 0.0% | 0.00% | – |
| Q4 2015 | $34,000 | -2.9% | 23,219 | 0.0% | 0.00% | – |
| Q3 2015 | $35,000 | -10.3% | 23,219 | 0.0% | 0.00% | – |
| Q2 2015 | $39,000 | +18.2% | 23,219 | 0.0% | 0.00% | – |
| Q1 2015 | $33,000 | -5.7% | 23,219 | 0.0% | 0.00% | – |
| Q4 2014 | $35,000 | -28.6% | 23,219 | 0.0% | 0.00% | – |
| Q3 2014 | $49,000 | – | 23,219 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spark Investment Management LLC | 308,500 | $462,000 | 0.08% |
| Perceptive Advisors | 200,000 | $302,000 | 0.02% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 29,675 | $45,000 | 0.02% |
| EXANE DERIVATIVES | 100,000 | $150,995,000 | 0.02% |
| PIPER SANDLER & CO. | 20,000 | $30,000 | 0.02% |
| Alyeska Investment Group, L.P. | 530,000 | $801,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 15,000 | $23,000 | 0.01% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 13,350 | $20,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 458,952 | $693,000 | 0.01% |
| WOLVERINE ASSET MANAGEMENT LLC | 1,605 | $388,000 | 0.01% |